BIOMAT Database Logo BIOMAT Database Logo

Effect of growth hormone therapy in two sisters with SHOX haploinsufficiency. 2009

Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan. turakami@med.nihon-u.ac.jp

UI MeSH Term Description Entries
D011884 Radius The outer shorter of the two bones of the FOREARM, lying parallel to the ULNA and partially revolving around it. Radial Tuberosity,Radial Tuberosities,Tuberosities, Radial,Tuberosity, Radial
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074122 Short Stature Homeobox Protein A homeodomain protein that is highly expressed in the nuclei of skeletal muscle, bone marrow, and osteogenic cells and has critical roles in growth and development. Its gene resides within PSEUDOAUTOSOMAL REGION 1 of X and Y chromosomes and mutations are associated with several growth disorders including LERI-WEIL SYNDROME; LANGER MESOMELIC DYSPLASIA; and SHORT STATURE, IDIOPATHIC, X-LINKED. GCFX Protein,PHOG Protein,SHOX Protein,SHOXY Protein
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018398 Homeodomain Proteins Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL). Homeo Domain Protein,Homeobox Protein,Homeobox Proteins,Homeodomain Protein,Homeoprotein,Homeoproteins,Homeotic Protein,Homeo Domain Proteins,Homeotic Proteins,Domain Protein, Homeo,Protein, Homeo Domain,Protein, Homeobox,Protein, Homeodomain,Protein, Homeotic,Proteins, Homeo Domain,Proteins, Homeobox,Proteins, Homeodomain,Proteins, Homeotic

Related Publications

Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.
June 2001, Endocrine journal,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.
September 2003, Journal of pediatric endocrinology & metabolism : JPEM,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
[SHOX haploinsufficiency].
May 2006, Nihon rinsho. Japanese journal of clinical medicine,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Familial growth and skeletal features associated with SHOX haploinsufficiency.
September 2003, Journal of pediatric endocrinology & metabolism : JPEM,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Height outcome of the recombinant human growth hormone treatment in patients with SHOX gene haploinsufficiency: a meta-analysis.
April 2013, Pharmacogenomics,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency.
June 2010, Journal of endocrinological investigation,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens.
April 2004, Endocrine journal,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
SHOX Whole Gene Duplications Are Overrepresented in SHOX Haploinsufficiency Phenotype Cohorts.
January 2022, Cytogenetic and genome research,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
SHOX haploinsufficiency and its modifying factors.
December 2002, Journal of pediatric endocrinology & metabolism : JPEM,
Tatsuhiko Urakami, and Maki Hasegawa, and Shigeo Morimoto, and Hiroshi Saitoh, and Hideo Mugishima
Y-chromosome microdeletions are not associated with SHOX haploinsufficiency.
November 2013, Human reproduction (Oxford, England),
Copied contents to your clipboard!